D-0231-2024 Class II Ongoing
FDA drug recall D-0231-2024 was initiated by Pharma Nobis LLC on Dec 21, 2023 and is designated Class II. Reason for recall: MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria. The recall status is ongoing. Affected quantity: 7,404 Bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- Jan 24, 2024
- Initiation Date
- Dec 21, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7,404 Bottles
Product Description
Freskaro refresh & revitalize Magnesium Citrate Saline Laxative Oral Solution Cherry Flavor 10 fl. oz, Manufactured by: Pharma Lobis, 7400 Alumax Dr., Texarkana, TX 75501, NDC 82645-312-10.
Reason for Recall
MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.
Distribution Pattern
Nationwide.
Code Information
Lot A80622; Exp. 11/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0231-2024
- openFDA file date
- Nov 3, 2026
- Loaded by RegDataLab
- Nov 4, 2026